Literature DB >> 6721996

Kinetic interactions of nadolol and propranolol with cimetidine.

K L Duchin, M A Stern, D A Willard, D N McKinstry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721996      PMCID: PMC1463400          DOI: 10.1111/j.1365-2125.1984.tb02379.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Determination of serum nadolol levels by GLC--selected ion monitoring mass spectrometry: comparison with a spectrofluorometric method.

Authors:  P T Funke; M F Malley; E Ivashkiv; A I Cohen
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

2.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

3.  The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat.

Authors:  O Pelkonen; J Puurunen
Journal:  Biochem Pharmacol       Date:  1980-11-15       Impact factor: 5.858

4.  Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.

Authors:  W Kirch; H Spahn; H Köhler; E E Ohnhaus; E Mutschler
Journal:  Klin Wochenschr       Date:  1982-11-15

5.  Cimetidine increases steady state plasma levels of propranolol.

Authors:  I W Reimann; U Klotz; B Siems; J Frölich
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Reduction of liver blood flow and propranolol metabolism by cimetidine.

Authors:  J Feely; G R Wilkinson; A J Wood
Journal:  N Engl J Med       Date:  1981-03-19       Impact factor: 91.245

  6 in total
  1 in total

1.  Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus.

Authors:  E Naline; B Sarria; O Ertzbischoff; P Ozanne; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.